Dipyridamole contains not less than 98.5% and not more than 101.5% of C24H40N8O4, calculated on the anhydrous basis.

共有 1 個藥物證書使用此成份

二吡待摩
Dipyridamole

• 申請商: 宇直泰貿易股份有限公司
• 適應症: 血小板集結降低藥
• 發證日期: 2019-11-12